"The light goes out of their eyes in about 3 years. This is not what they signed up for." -- Clark Coler, MD, of Swedish ...

Critics of these alternative plans say the major issues occur when people use them as primary insurance and don't realize the ...

The problem is that regulatory incentives are fundamentally asymmetric. Approving a dangerous therapy generates headlines, ...

Donald Trump's physician says the president is in "excellent health" and is "fully fit" to serve as commander in chief after a medical exam Tuesday at Walter Reed National Military Medical Center that ...

The adjuvant treatment of RET fusion-positive non-small-cell lung cancer (NSCLC) following potentially curative surgery or radiotherapy has a new standard of care, researchers reported here. In a ...

It determines patient cost-sharing and a benchmark for payer offers, but it may be far below historical out-of-network reimbursement. There is no concrete data to measure the number of claims ...

In the phase III study, tafasitamab (Monjuvi) and lenalidomide (Revlimid) were added to R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone) for frontline therapy in patients ...

Patients in full remission from endometrial cancer who underwent fertility-preserving treatment before cancer treatment had less IVF success than matched controls. The question remains as to what ...

Legally, the Laikipia plan walks a dangerous constitutional tightrope. While the government possesses broad quarantine powers ...

The Vaccines and Related Biological Products Advisory Committee (VRBPAC) also discussed the need to target the long-simmering ...

Crohn's disease and ulcerative colitis -- boosts the risk of mental diseases such as depression and anxiety. Meanwhile, these ...

Dozens of doctors are routinely performing risky vascular procedures in medical offices, generating tens of millions of ...